Can optometrists diagnose glaucoma accurately?

Article

With additional training, optometrists are at least as accurate as junior ophthalmologists in diagnosing glaucoma.

With additional training, optometrists are at least as accurate as junior ophthalmologists in diagnosing glaucoma, according to a report published in the December issue of the British Journal of Ophthalmology.

Augusto Azuara-Blanco from Aberdeen Royal Infirmary and colleagues from the University of Aberdeen, Aberdeen, Scotland compared the diagnostic performance of accredited glaucoma optometrists (AGOs) for both the diagnosis of glaucoma and the decision to treat with that of routine hospital eye care, against a reference standard of expert opinion (a consultant ophthalmologist with a special interest in glaucoma).

A total of 100 people took part in the directly comparative, masked performance study. Subjects suspected of having glaucoma underwent a full ophthalmic assessment in both a newly established community optometry led glaucoma management scheme and a consultant led hospital eye service.

There was substantial agreement between the AGO and the consultant ophthalmologist in diagnosing glaucoma (89%) and agreement over the need for treatment was also high at 88%. Agreement between trainee and consultant ophthalmologist in the diagnosis and treatment recommendations were moderate (83%). The diagnostic accuracy of the optometrists was found to be high (0.93) but lower for sensitivity (0.76). The differences in sensitivity and specificity between AGO and junior ophthalmologist were not statistically significant.

The authors of this report concluded that, with additional training in glaucoma, optometrists can be at least as accurate as junior ophthalmologists in diagnosing the disease.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.